Anticancer properties of chemically synthesized compounds have been evaluated for efficacy and selectivity. A new ligand PTCP 3, 7, phenanthrene) and its three new ruthenium(II) polypyridyl complexes [Ru(N-N) The relationship between anti-proliferation and molecular interaction mechanism of the complexes was also elucidated. The apoptosis was assayed by flow cytometry. The changes of mitochondrial membrane potential and the ROS levels were measured by flow cytometry. The cell invasion, cell cycle arrest and the expression of Bcl-2 family proteins were studied in detail. N-Acetylcysteine (NAC) was used in several experiments to testify the effect of the complexes on apoptosis. The results demonstrate that the complexes induce apoptosis in SGC-7901 cells through a ROS-mediated mitochondrial dysfunction pathway, which was accompanied by the regulation of Bcl-2 family proteins. In addition, the interaction of the complexes with calf thymus DNA (CT-DNA) shows that the complexes interact with DNA through partial intercalation mode.
Introduction
Cisplatin and its derivatives are still used in more than 50% of the treatment drugs for cancer patients. [1] [2] [3] [4] Platinum-based compounds are the most widely used clinically. However, the clinical drawbacks of cisplatin are also obvious, including the limited applicability, the acquired resistance, and the serious side effects, such as neurotoxicity and nephrotoxicity. 5, 6 Thus, a number of other metal-based drugs have been sought with the hope of nding an inexpensive metal complex with fewer adverse effects and improved therapeutic value. It is well known that ruthenium compounds with special properties to mimic iron by binding to biological molecules, reduce general toxicity and strong affinity to cancer tissues than normal tissues, which make them be potential candidates as anticancer drugs. [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] So far, two ruthenium complexes have been proved to display potential anticancer activities; KP1019 and KP1339 have entered clinical trials. 17, 18 These complexes exhibit some advantages over cisplatin, for instance, their activity against cisplatin-resistant cancer cell lines and higher selectivity for cancer cells over normal cells, which can reduce side effects.
19-22
Several mechanisms have been proposed to elucidate the anticancer activities of ruthenium complexes, including the inhibition of metastasis, 23, 24 interaction with DNA and proteins, 25, 26 generation of ROS, 27 induction of apoptosis. 28 Based on our previous work, [29] [30] [31] [32] [33] we found that ruthenium(II) polypyridyl complexes appear to show high activity against cancer cells. To obtain more information on the anticancer activity of ruthenium complexes, in this study, a new ligand PTCP (PTCP ¼ 2-phenanthren-9-yl-1H-1,3,7,8-tetraazacyclopenta[l]phenanthrene) and its three Ru(II) polypyridyl complexes: [Ru(N-N) 2 -(PTCP)](ClO 4 ) 2 (N-N: phen ¼ 1,10-phenanthroline 1; dmp ¼ 2,9-dimethyl-1,10-phenanthroline 2 and ttbpy ¼ 4,4 0 -di-tert-butyl-2,2 0 -bipyridine 3, Scheme 1) were synthesized and characterized by elemental analysis, ESI-MS, IR, 1 HNMR, 13 C NMR. The cytotoxicity in vitro of the ligand and complexes toward SGC-7901, HepG2, HeLa, SiHa and normal NIH3T3 cells was evaluated by MTT method. The apoptosis in SGC-7901 cells induced by the complexes was quantied with Annexin V/PI staining method. The cell cycle arrest, reactive oxygen species and mitochondrial membrane potential (MMP) in SGC-7901 cells were detected by ow cytometry. The matrigel invasion assay was investigated to evaluate the capacity of the complexes to inhibit the invasion of SGC-7901 cells. The expression of Bcl-2 family proteins was studied by western blot. Additionally, the NAC was used in the cell viability, ROS levels and MMP assay to compare with those incubated without NAC, which was used to further explore the apoptotic-inducing mechanism. The DNAbinding of the complexes with CT-DNA was performed by electronic absorption titration, luminescence spectra, viscosity measurements and molecular docking.
Results and discussion

Synthesis and characterization
The ligand PTCP was prepared through condensation of 1,10-phenanthroline-5,6-dione with phenanthrene-9-carbaldehyde using a similar method to that described by Steck and Day. 34 The ruthenium(II) complexes were synthesized by the direct reaction with the appropriate precursor complexes in ethylene glycol. In the spectra of ESI-MS for the ruthenium(II) complexes, the expected signal of [M À 2ClO 4 ] 2+ was observed. The measured molecular weights were consistent with the expected values. In the 13 C NMR spectra for complexes 2 and 3, the signals in the range of 24-36 ppm are attributed to the methyl group. The UV-vis and luminescence spectra of the complexes (5 mM) in PBS solution were detected. The UV-vis spectra of the complexes consist of two well resolved bands in the range 200-600 nm. The high-energy absorption bands below 300 nm are attributed to an intraligand (IL) p-p* transition. The low-energy absorption bands at 450-500 nm are assigned to a metal-toligand charge-transfer (MLCT) transition.
2.2. DNA-binding studies 2.2.1. Electronic absorption titration. The absorption spectra of the complexes (5 mM) 1-3 in the absence or presence of increasing amounts of CT-DNA are shown in Fig. 1 Fig. 2 , upon addition of CT-DNA, the emission intensity caused by 1 (a) grows about 1.78 times larger than that in the absence of DNA. This implies that complex 1 can interact with DNA and be protected by DNA efficiently, since the hydrophobic environment inside the DNA helix reduces the accessibility of solvent water molecules to the complex and the complex mobility is restricted at the binding site, leading to a decrease of the vibrational modes of relaxation. However, with the increasing concentration of DNA, the emission intensity induced by complex 3 (b) decreases about 1.73 times than that of the original.
Scheme 1
The synthetic route of ligand and complexes.
Viscosity measurements
Viscosity measurements that are sensitive to length change of DNA are regarded as the least ambiguous and the most critical tests of binding mode in solution in the absence of crystallographic structural data or NMR spectra. 37, 38 It is popularly accepted that a classical intercalation mode results in lengthening the DNA helix, as base pairs are separated to accommodate the binding ligand, leading to the increase of DNA viscosity. In contrast, a partial and/or non-classical intercalation of ligand could bend (or kink) the DNA helix, reduce its effective length and, concomitantly, its viscosity. 37, 38 As shown in Fig. 3 , the relative viscosity of DNA increases at a low ratio of [Ru]/[DNA]. However, on increasing concentration of complexes 1-3, the relative viscosity of DNA solution decreases. The viscosity results demonstrate that the complexes interact with DNA through partial intercalation.
Molecular docking with DNA
The molecular docking technique can contribute to rational drug design and mechanistic studies by placing a small molecule into the binding site of the DNA target specic region mainly in a non-covalent mode. 39 To explore the most feasible binding site, interaction mode and binding affinity docking studies have been performed on complexes 1-3 with B-DNA (PDB ID: 1BNA). As shown in Fig. 4 , the complexes interact with DNA through partial intercalation at the major groove. The resulting relative binding energies of docked 1, 2 and 3 with DNA are À37.18, À31.95 and À9.70 kJ mol À1 , respectively. The more negative binding energy shows more potent DNA-binding affinity. Thus, the DNA-binding affinities follow the order of 1 > 2 > 3. This is completely consistent with the results obtained from the electronic absorption titration. In addition, the results indicate that there are certain hydrogen-bonding interaction between the complexes and DNA. The length of these hydrogen 
Cytotoxic activity in vitro assay
The cytotoxic activity in vitro of the ligand and complexes against cancer cell lines was determined by MTT method, and cisplatin was used as a positive reference. 
. 40 Through comparison of the cytotoxic activity of the same complex against different cancer cell lines or different complexes against the same cancer cell line, we conclude that (1) the same complex shows different cytotoxic effect on the different cell growth, this may be related to the amount which the complex enters into the cell. (2) Different complexes also displays different cytotoxic activity against the same cancer cell, this may be caused by different structures of the different complexes. Comparing the IC 50 values of complexes toward the cancer cell lines, we found that SGC-7901 was more sensitive to complexes than others. Thus this cell was selected for the following experiments.
Apoptosis assay by ow cytometry
Apoptosis is a normal phenomenon in the process of development and growth in organisms, 41 and many diseases including cancer have been connected with the excessive activation or inhibition of apoptotic signaling pathway. 42, 43 To evaluate the effect of the complexes on apoptosis in SGC-7901 cell, we used ow cytometry analysis to determine the percentage of apoptotic cells. As shown in Fig. 5 , in the control (a), the percentage of the apoptotic cells is 0.38%. SGC-7901 cells were treated with 12.5 and 25.0 mM of complexes 1 (b and c), 2 (d and e) and 3 (f and g) for 24 h, the percentages of apoptotic cells are 5.52% and 7.24% for 1, 1.61% and 1.74% for 2, 5.33% and 28.5% for 3, respectively. Complex 3 shows the highest apoptotic effect on SGC-7901 cells among these complexes. Furthermore, the complexes induce apoptosis in a concentration-dependent manner. The apoptotic effect of the complexes against SGC-7901 cell follows the order of 3 > 1 > 2. This is not consistent with the order of cytotoxic activity of 2 > 1 > 3.
DNA damage studies
DNA damage was quantied through the single cell gel electrophoresis, using the comet assay.
44 DNA fragmentation is a hallmark of apoptosis, mitotic catastrophe or both.
45 DNA strand breaks were detected in SGC-7901 cells upon treatment with the complexes in a cell-based alkaline comet assay, cisplatin was used as a positive control. As shown in Fig. 6 , in the control (a), SGC-7901 cells fail to show any comet-like appearance. Exposure of SGC-7901 cells to cisplatin (2.5 mM, b) and 12.5 mM of complexes 1 (c), 2 (d) and 3 (e) for 24 h induced considerable strand breakage on chromosomal DNA and led to the appearance of an obscure "halo" around the nucleus of the SGC-7901 cells. The statistically signicant and well-formed comets were observed that indicated severe DNA damage. The results of the comet assay reveal that the DNA of a single cell underwent degradation as a consequence of direct DNA damage or rapid apoptosis. 
Determination of the level of reactive oxygen species (ROS)
It is well known that pharmacological ROS damage might be a potential element to eliminate cancer cells, which suggests that ROS can induce apoptosis in cancer cells. 47 The literature reported that there is an inseparable relationship between the apoptosis or senescence process in cancer cells and the levels of ROS. 48 Thus we speculated that the apoptosis of SGC-7901 cells may be mediated by ROS. To verify whether or not our speculation is correct, DCFH-DA was used as a uorescent probe to determine the change of the level of the ROS induced by the complexes. Inside the cell, DCFH-DA is transferred to a uorescent product, namely, dichlorouorescein (DCF). 49, 50 As shown in Fig. 7A , in the control (a), no obvious green spots were found. Aer the treatment of SGC-7901 cells with 12.5 mM of complexes 1 (b), 2 (c) and 3 (d) for 24 h, the bright green spots were observed. Comparing the green uorescent intensity, complex 2 induces weaker green uorescence than those induced by complexes 1 and 3 under identical conditions. To quantitatively compare the effect of the complexes on ROS levels, the DCF uorescent intensity is determined by ow cytometry. As shown in Fig. 7B , in the control (a), the DCF uorescence intensity is 10.3. When SGC-7901 cells were incubated with 25 mM of complexes 1 (c), 2 (e) and 3 (g), the DCF uorescent intensity increases 45.4, 5.0 and 60.6 times than the original, respectively. The effect of the complexes on ROS levels follows the order of 3 > 1 > 2. This is consistent with the apoptotic effect. Moreover, the ROS levels induced by the complexes show a concentration-dependent manner. N-Acetylcysteine (NAC, 5 mM) is an inhibitor to inhibit the production of ROS. In the presence of NAC, the effect of the complexes on the ROS levels are shown in Fig. 7C , in the control (a), the DCF uorescence intensity is 12.8. Aer SGC-7901 cells were exposed to 12.5 mM of complexes 1 (b), 2 (c) and 3 (d), the DCF uorescence intensity increases 11.2, 1.88 and 16.9 times than the original. The increasing degrees are less than those in the absence of NAC (17.6 times for 1, 3.6 times for 2 and 24.4 times for 3). This demonstrates that the addition of NAC into the complexes lead to a decrease in the ROS levels. Although complex 2 shows higher cytotoxic activity against SGC-7901 cell, this complex displays lower effect on the production of ROS levels. Additionally, we also investigated the relationship between cell viability and ROS levels. As shown in Fig. 7D , in the presence of NAC, the cell viability induced by the complexes increases, which indicates that ROS levels can enhance the ability of the complexes to kill cancer cells. 
Mitochondrial membrane potential detection
The inner mitochondrial membrane is a main position of production of ROS produced as co-products of the mitochondrial electron transport chain. Mitochondria are a critical organelle involved in maintaining cellular homeostasis and producing cellular energy (adenosine triphosphate, ATP) depending on oxidative phosphorylation, 51, 52 which induces apoptosis as the intrinsic apoptotic pathway and adjusts calcium homeostasis. 53, 54 It is conrmed that the mitochondria membrane potential (MMP, DJ m ) is a major symbol in the early apoptosis, and JC-1 was used as uorescent probe to measure the MMP. [55] [56] [57] The above mentioned ROS levels assay shows that apoptosis in SGC-7901 cells treated with complexes 1-3 was induced by excessive release of ROS. According to the mitochondrial membrane potential assay kit, JC-1 accumulates in matrix to form JC-1 aggregates which can emit red uorescence corresponding to high mitochondrial membrane potential. On the contrast, JC-1 forms monomer to emit green uorescence corresponding to low mitochondrial membrane potential. The ratio of red/green uorescence intensity was determined by ow cytometry. As shown in Fig. 8A , in the control (a, up and down), the ratio of the red/green uorescence is 6.24. The complexes (12.5 mM) treated SGC-7901 cells for 24 h, the ratios of the red/green are 1.44, 0.53 and 0.42 for 1-3, respectively. The reduction in the ratio indicates that the red uorescence decreases and the green uorescence increases, which suggests that the complexes can induce a reduction in the mitochondrial membrane potential. To explore the inuence of NAC on the changes in mitochondrial membrane potential, in the presence of NAC, the ratios of the red/green uorescence are shown in Fig. 8B .
Comparing the ratio of the red/green uorescence in the presence of NAC with those in the absence of NAC, the ratios in the presence of NAC increase, which indicates that high ROS level induces more changes in the mitochondrial membrane potential.
Cell cycle arrest studies
DNA is the most highlight of the target for anticancer drugs to exert toxic effects. 58 Most anti-tumor drugs eliminate cancer cells by inducing apoptosis, 59,60 while others cause cell death via disturbing the mitotic process. 61 In order to evaluate the effect of the complexes on cell cycle distribution of SGC-7901, the cell cycle arrest of SGC-7901 cells were investigated by ow cytometry. As shown in Fig. 9 , in the control, the percentage in the cells at G0/G1 is 55.60 (AE3.2)%. Aer the treatment of SGC-7901 cells with 12.5 mM of the complexes, an increase of 7.27% for 1, 2.69% for 2 and 9.66% for 3 in the percentage at G0/G1 phase was observed, which was accompanied by the corresponding reduction of 5.22% for 1, 4.53% for 2 and 2.52% for 3 in the percentage of cells in the G2/M phase. The data demonstrates that the complexes inhibit the cell growth in the G0/G1 phase.
Cell invasion studies
Cell invasion is a process associated with cancer metastasis, which refers to the cell migration through an extracellular matrix. 62 To investigate the efficiency of complexes 1, 2 and 3 on inhibiting the cell invasion, the Matrigel invasion assay was performed. As shown in Fig. 10A and B, the percentage of inhibiting the cell invasion is 41.4% for 1, 44.7% for 2 and 28.9% for 3 aer SGC-7901 cells were exposed to 25.0 mM of the complexes, respectively. It is clear that the inhibiting effects of the complexes display a concentration-dependent manner. The effect of the complexes at 25.0 mM on the cell invasion follows the order of 2 > 1 > 3. This order is consistent with the cytotoxic activity of the complexes toward SGC-7901 cells.
Autophagy induced by the complexes
Autophagy is an evolutionarily conserved process degrading cellular proteins and cytoplasmic organelles, in which the phagophores surround and pack organelles to form autophagosomes. 63 The effect of the complexes on autophagy was studied using monodansylcadaverine (MDC) as uorescent probe. MDC is a specic, in vivo marker for autophagic vacuoles, and MDC incorporation is an indicator of autophagic activity. 64 As shown in Fig. 11A, in the control (a) , no obvious spots are found. The treatment of SGC-7901 cells with 12.5 mM of complexes 1 and 2 for 24 h, no uorescence spots are observed (data not present), which indicates that complexes 1 and 2 can not induce autophagy. However, SGC-7901 cells were treated with complex 3 (b), the MDC labeling green uorescent points in the cytoplasm were discovered, which suggests that the autophagic vacuoles were formed. The MDC uorescence intensity was determined by ow cytometry. As shown in Fig. 11B, in the control (a) , the uorescence intensity is 2.72. Aer SGC-7901 cells were exposed to 12.5 mM of complex 3 for 24 h, the uorescence intensity is 8.16. The MDC uorescence intensity increases 3 times than the original, which also indicates that complex 3 can induce autophagy.
Western blot analysis
The transduction of apoptotic signals requires the activation of a cascade of cysteine proteases and caspases. Caspase 3, in particular, plays a central role in the execution of apoptosis.
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Bcl-2 family proteins maintain the balance of cell death and survival, which plays a key role in the regulation of apoptosis via the control of mitochondrial membrane. 66 NAC was used to investigate whether ROS inuence the expression of those proteins or not. Aer treatment of SGC-7901 cells with 12.5 mM of complexes 1-3, the results are shown in Fig. 12 . Complexes 1-3 result in an increase in the expression of caspase-3, Bax and Bid compared to the control. In the presence of NAC, the expression of caspase 3, Bcl-2 and Bcl-x down-regulates, whereas the expression of Bax and Bid up-regulates. This shows that NAC can regulate the expression of Bcl-2 family proteins. 
Conclusions
In summary, we have synthesized three ruthenium(II) complexes and investigate DNA-binding and the probable anticancer mechanism in vitro of the complexes against SGC-7901. These complexes interact with CT-DNA through partial intercalative mode at DNA major groove. The complexes show high cytotoxic activity toward SGC-7901 cells. They can increase the ROS levels and induce a decrease in the mitochondrial membrane potential. The complexes inhibit the cell growth at G0/G1 phase, and down-regulate the expression of Bcl-2 and Bcl-x, and up-regulate the expression of Bax and Bid. Take above together, we consider that the complexes induce apoptosis in SGC-7901 cell through the following two pathways (Fig. 13): (1) rstly, the complexes enhance ROS levels, and then the increase of ROS levels induces a decrease in the mitochondrial membrane potential. Secondly, the changes of mitochondrial membrane potential activate the expression of caspase 3. Thirdly, the activation of caspase stimulates the cell apoptosis. (2) The complexes can cause DNA damage, and then the complexes inhibit the cell growth at G0/G1 phase. Finally, the complexes induce cell apoptosis. This work will be helpful for design and synthesis of new ruthenium(II) complexes as potent anticancer drugs.
Experimental
Materials and methods
The reagents and solvents used in the experiments were purchased commercially and used without further purication unless special statement. Ultrapure water was used in all experiments Calf Thymus DNA (CT-DNA) was obtained from the Sino-American Biotechnology Company. pBR 322 DNA was obtained from Shanghai Sangon Biological Engineering & Services Co., Ltd. Doubly distilled water was used to prepare buffers (5 mM Tris(hydroxymethylaminomethane)-HCl, 50 mM NaCl, pH ¼ 7.2). A solution of calf thymus DNA in the buffer gave a ratio of UV absorbance at 260 and 280 nm of ca. 1.8-1.9 : 1, indicating that the DNA was sufficiently free of protein. 67 The DNA concentration per nucleotide was determined by absorption spectroscopy using the molar absorption coefficient (6600 M À1 cm À1 ) at 260 nm. , 1943w, 1689s, 1607m, 1545m,  1494s, 1427m, 1397m, 1246w, 1196w, 1072s, 1032m, 1012m , 894s, 804s, 738s, 681m, 624w. 1970m, 1681w, 1601m, 1577w, 1542m, 1492s, 1445w , Fig. 13 The molecular mechanism of the complexes inducing apoptosis in SGC-7901 cell.
1408s ).
DNA-binding studies
The absorption titrations of ruthenium(II) complex in buffer were performed by using a xed ruthenium complex concentration (20 mM) to which the DNA stock solution were added.
Ruthenium-DNA solutions were allowed to incubate for 5 min before the absorption spectra were recorded. In order to further illustrate the binding strength of the complex, the intrinsic binding constant K with CT-DNA was obtained by monitored the change in the absorbance at metal-to-ligand transfer (MLCT), with increasing concentration of DNA, the following equation was applied. 76 where h is the viscosity of DNA in the presence of complex and h 0 is the viscosity of DNA alone.
Molecular docking
The optimized structures of the complexes were performed using density function theory (DFT) B3LYP. The crystal data of the B-DNA dodecamer d(CGCGAATTCGCG) 2 (PDB 1D:1BNA) were downloaded from the Protein Data Bank. 77 The water molecules and the ligands were removed from the 1BNA, and Gasteiger charges were added to the complexes by Autodock 4.2 Tools (ADT) before performing docking calculations. The binding site was centered on the DNA molecule and a grid box was created with 60 Â 60 Â 60 points in which almost involved the entire DNA molecule. The rigid docking protocol and 100 runs of the Lamarckian genetic algorithm for searching ligand conformations were performed.
Cytotoxicity in vitro assay
Cell viability was determined by MTT assay. 78 Cancer cells (8 Â 10 3 cells per well) were seeded in 96-well for 24 h. Cells was incubated with the tested compounds to achieve nal concentrations ranging from 10 À6 to 10 À4 M. Control wells were prepared by addition of culture medium (100 mL) and cisplatin was used as a positive control. Aer 48 h incubation, 10 mL of MTT dye solution (5 mg mL À1 ) was added to each well. Aer incubation at 37 C for 4 h, buffer (100 mL) containing dimethylformamide (50%) and sodium dodecyl sulfate (20%) was added to transform MTT to a purple formazan dye. The optical density of each well was then measured for three times to obtain the mean values. The IC 50 values were analyzed by soware of SPSS.
DNA damage assay
DNA damage was investigated by means of comet assay. SGC-7901 cells in culture medium were incubated with 12.5 mM of the complex for 24 h at 37 C. The cells were harvested by a trypsinization process at 24 h. A total of 100 mL of 0.5% normal agarose in PBS was dropped gently onto a fully frosted microslide, covered immediately with a coverslip, and then placed at 4 C for 10 min. The coverslip was removed aer the gel had been set. A mixture of 50 mL of the cell suspension (200 cells per mL) mixed with 50 mL of 1% low melting agarose was preserved at 37 C. A total of 100 mL of this mixture was applied quickly on top of the gel, coated over the microslide, covered immediately with a coverslip, and then placed at 4 C for 10 min. The coverslip was again removed aer the gel had been set. A third coating of 50 mL of 0.5% low melting agarose was placed on the gel and allowed to place at 4 C for 15 min. Aer solidication of the agarose, the coverslips were removed, and the slides were immersed in an ice-cold lysis solution (2.5 M NaCl, 100 mM EDTA, 10 mM Tris, 90 mM sodium sarcosinate, NaOH, pH 10, 1% Triton X-100 and 10% DMSO) and placed in a refrigerator at 4 C for 2 h. All of the above operations were performed under low lighting conditions to avoid additional DNA damage. The slides, aer removal from the lysis solution, were placed horizontally in an electrophoresis chamber. The reservoirs were lled with an electrophoresis buffer (300 mM NaOH, 1.2 mM EDTA) until the slides were just immersed in it, and the DNA was allowed to unwind for 30 min in electrophoresis solution. Then the electrophoresis was carried out at 25 V and 300 mA for 20 min. Aer electrophoresis, the slides were removed, washed thrice in a neutralization buffer (400 mM Tris, HCl, pH 7.5). Cells were stained with 20 mL of EB (20 mg mL À1 ) in the dark for 20 min. The slides were washed in chilled distilled water for 10 min to neutralize the excess alkali, air-dried and scored for comets by uorescent microscopy. ) and 20 mL of propidium iodide (0.02 mg mL À1 ) were added to the cell suspensions and the mixtures were incubated at 37 C for 30 min. The samples were then analyzed with a FACS Calibur ow cytometry. The number of cells analyzed for each sample was 10 000.
Annexin V-FITC apoptosis detection
Anti-metastasis effect
The BD BioCoat™ Matrigel™ invasion chamber (BD Biosciences) was used according to the manufacturer's instructions.
Compounds were dissolved in cell media at the desired concentration and added into Matrigel. Twenty-ve thousands of SGC-7901 cells in serum free media were then seeded in the top chamber of the two chamber Matrigel system. To the low compartment, RPMI and 5% FBS were added as chemoattractant. Cells were allowed to invade for 24 h. Aer incubation, non-invading cells were removed from the upper surface and cells on the lower surface were xed with 4% paraformaldehyde and stained with 0.1% of crystal violet. Membranes were photographed and the invading cells were counted under a light microscope. Mean values from three independent assays were calculated.
Autophagy studies
SGC-7901 cells were seeded onto chamber slides in 12-well plates and incubated for 24 h. The cells were cultured in RPMI 1640 supplemented with 10% of FBS and incubated at 37 C in 5% CO 2 . The medium was removed and replaced with medium (nal DMSO concentration, 0.05% v/v) containing the complex for 24 h. The medium was removed again, and the cells were washed with ice-cold PBS twice. Then the cells were stained with MDC (monodansylcadaverine) solution (50 mM) for 10 min and washed with PBS twice. The cells were observed and imaged under uorescence microscope.
Western blot analysis
SGC-7901 cells were seeded in 3.5 cm dishes for 24 h and incubated with 12.5 mM of complexes 1, 2 and 3 in the presence of 10% FBS. Then cells were harvested in lysis buffer. Aer sonication, the samples were centrifuged for 20 min at 13 000g. The protein concentration of the supernatant was determined by BCA assay. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis was done loading equal amount of proteins per lane. Gels were then transferred to poly(vinylidene diuoride) membranes (Millipore) and blocked with 5% non-fat milk in TBST (20 mM Tris-HCl, 150 mM NaCl, 0.05% Tween 20, pH 8.0) buffer for 1 h. The membranes were incubated with primary antibodies at 1 : 5000 dilution in 5% non-fat milk overnight at 4 C, and aer washed four times with TBST for a total of 30 min, then the secondary antibodies conjugated with horseradish peroxidase at 1 : 5000 dilution for 1 h at room temperature and washed four times with TBST. The blots were visualized with the Amersham ECL Plus western blotting detection reagents according to the manufacturer's instructions. To assess the presence of comparable amount of proteins in each lane, the membranes were stripped nally to detect the b-actin.
Data analysis
All data was expressed as means AE SD. Statistical signicance was evaluated by a t-test. Differences were considered to be signicant when a *p value was less than 0.05.
